IMX-110 combined with Tislelizumab
IMX-110-002
Phase 2 small_molecule active
Quick answer
IMX-110 combined with Tislelizumab for Advanced Solid Tumor is a Phase 2 program (small_molecule) at Immix Biopharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Immix Biopharma
- Indication
- Advanced Solid Tumor
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active